{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:43Z","timestamp":1761511663576},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1283,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,7]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Sexual dimorphism of 11 \u03b2 hydroxysteroid dehydrogenase activity (11 \u03b2 HSD) as measured by the urinary 11\u2010OH\/11\u2010oxo cortisol metabolite ratio has been documented in healthy subjects. Since body composition, fat distribution and insulin sensitivity vary between the sexes we have investigated whether these factors may account for the observed difference. Studies were performed in ACTH deficient hypopituitary subjects to eliminate the effect of feedback modulation of cortisol secretion.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN AND PATIENTS<\/jats:title><jats:p>44 hypopituitary patients, (m:f, 32:12), median age 51 years, median weight 86\u2003kg, on hydrocortisone and other replacement therapy as appropriate were studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENT<\/jats:title><jats:p>Urine 11\u2010OH\/11\u2010 oxo cortisol metabolites and serum and urine cortisone (E) and cortisol (F) were measured in relation to total cortisol metabolites and cortisol binding globulin; fat distribution was assessed by Dual Energy X\u2010ray absorptiometry (DXA), and insulin sensitivity by homeostatic model of assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Cortisol bioavailability (total urine cortisol metabolites, urine free cortisol and cortisol binding globulin) was similar in both sexes. The 11\u2010OH\/11\u2010oxo ratio was lower in females than males (median; 0.99 <jats:italic>vs <\/jats:italic>1.3, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.03) while thyroid status was similar. Females had higher percentage fat (median 47.7 <jats:italic>vs <\/jats:italic>34.9, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01); total fat (median 39.5 <jats:italic>vs <\/jats:italic>34.9 kg, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01), android fat (median 9.1 <jats:italic>vs <\/jats:italic>6.6 kg, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01); gynoid fat (median; 9.9 <jats:italic>vs <\/jats:italic>6.8 kg, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) and lower insulin sensitivity (median 15.3 <jats:italic>vs <\/jats:italic>30.6, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). In all subjects, the 11\u2010OH\/11\u2010 oxo ratio was inversely related to body weight (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01), % fat (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), total fat (<jats:italic>P<\/jats:italic>\u2003&lt; 0.01), android fat (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01), gynoid fat, (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) and directly correlated to insulin sensitivity, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01. Stepwise regression analysis showed gynoid fat to be the most important factor determining the 11\u2010OH\/11\u2010oxo ratio. In 24 subjects (f\u2003:\u2003m, 8\u2003:16) on exogenous sex steroid therapy insulin sensitivity was similar but the sexual dimorphism of the 11\u2010OH\/11\u2010oxo ratio remained unchanged (median; 1.0 <jats:italic>vs <\/jats:italic>1.7, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). The urine and serum F and E and their ratio (F\/E) were similar in these groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>These data confirm the presence of sexual dimorphism in 11 \u03b2\u2010hydroxysteroid dehydrogenase activity in hypopituitary patients as described in normal individuals. This is the first <jats:italic>in vivo <\/jats:italic>evidence that this dimorphism is related to body composition. Our findings suggest that sexual dimorphism may be determined by the activity of type 1 and not type 2 11 \u03b2\u2010hydroxysteroid dehydrogenase.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00494.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:37:33Z","timestamp":1047379053000},"page":"13-20","source":"Crossref","is-referenced-by-count":49,"title":["Sexual dimorphism in 11 \u03b2 hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects"],"prefix":"10.1111","volume":"49","author":[{"given":"Jolanta U","family":"Weaver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman F","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P","family":"Monson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,5,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(95)03501-W"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2471061.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.39.6.627"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11222-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.10.3002"},{"key":"e_1_2_6_7_2","first-page":"241","article-title":"Thyroid hormone effects on steroid metabolism","volume":"53","author":"Gordon G.G.","year":"1977","journal-title":"Bulletin of the New York Academy of Sciences"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-2-326"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.136.11.4754"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1390027"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/000456328502200501"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.00853.x"},{"issue":"2","key":"e_1_2_6_14_2","first-page":"100","article-title":"Steroid metabolism in healthy men and women","volume":"147","author":"Raven P.W.","year":"1995","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90140-J"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402173300703"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1993.tb00720.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01924.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00818-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb03537.x"},{"issue":"1","key":"e_1_2_6_21_2","first-page":"290","article-title":"Capillary cortisol measurements in assessment of hydrocortisone replacement therapy in hypopituitary adults","volume":"144","author":"Weaver J.U.","year":"1995","journal-title":"Journal of Endocrinology"},{"issue":"1","key":"e_1_2_6_22_2","first-page":"291","article-title":"The effect of unbound plasma cortisol on plasma fibrinogen and other putative risk factors for ischaemic heart disease in hypopituitary adults","volume":"144","author":"Weaver J.U.","year":"1995","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.1.153"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb01830.x"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00494.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00494.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00494.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:56:45Z","timestamp":1698447405000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00494.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00494.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00494.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}